Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies Inc
Dec 02, 2025 22:26:45
Share to 
According to market news, Nasdaq-listed biotech company Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies Inc.
Previously, it was reported that Hyperliquid Strategies submitted an S-1 filing to raise up to $1 billion, which may be used to purchase HYPE tokens.
Latest News
Data: The meme coin sector is experiencing a strong overall increase, with BONK rising by 38.72% in 24 hours
ChainCatcher
Jan 04, 2026 23:26:47
Hotcoin Research | Review of Leading Perp DEX: Cool Reflections Amidst Data Frenzy and Outlook for 2026
ChainCatcher
Jan 04, 2026 22:52:38
The top 100 listed companies hold a total of 1,090,949 BTC, and only 5 companies increased their BTC holdings in the past 7 days
ChainCatcher
Jan 04, 2026 22:35:45
Data: CHR rose over 12%, MTL and RED reached new highs this week
ChainCatcher
Jan 04, 2026 22:30:26
Binance Alpha will list Depinsim (ESIM) on January 5th.
ChainCatcher
Jan 04, 2026 22:05:11
